GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » Interest Income

Ildong Pharmaceutical Co (XKRX:249420) Interest Income : ₩1,195 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ildong Pharmaceutical Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Ildong Pharmaceutical Co's interest income for the three months ended in Sep. 2024 was ₩352 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ₩1,195 Mil.

Ildong Pharmaceutical Co Interest Income Historical Data

The historical data trend for Ildong Pharmaceutical Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ildong Pharmaceutical Co Interest Income Chart

Ildong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Income
Get a 7-Day Free Trial 342.64 260.18 569.37 1,551.85 1,093.17

Ildong Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.95 377.52 205.38 260.15 351.68

Ildong Pharmaceutical Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,195 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ildong Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » Interest Income
Comparable Companies
XKRX:170900 XKRX:243070 XKRX:003000 XKRX:003520 XKRX:041960 XKRX:206640 XKRX:206650 XKRX:200670 XKRX:033270 XKRX:047920 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
2 Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR, 137-733
Website
http://www.ildong.com
Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.

Ildong Pharmaceutical Co Headlines

No Headlines